Literature DB >> 15253936

Coordinated regulation of gene expression by Brn3a in developing sensory ganglia.

S Raisa Eng1, Jason Lanier, Natalia Fedtsova, Eric E Turner.   

Abstract

Mice lacking the POU-domain transcription factor Brn3a exhibit marked defects in sensory axon growth and abnormal sensory apoptosis. We have determined the regulatory targets of Brn3a in the developing trigeminal ganglion using microarray analysis of Brn3a mutant mice. These results show that Brn3 mediates the coordinated expression of neurotransmitter systems, ion channels, structural components of axons and inter- and intracellular signaling systems. Loss of Brn3a also results in the ectopic expression of transcription factors normally detected in earlier developmental stages and in other areas of the nervous system. Target gene expression is normal in heterozygous mice, consistent with prior work showing that autoregulation by Brn3a results in gene dosage compensation. Detailed examination of the expression of several of these downstream genes reveals that the regulatory role of Brn3a in the trigeminal ganglion appears to be conserved in more posterior sensory ganglia but not in the CNS neurons that express this factor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15253936     DOI: 10.1242/dev.01260

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  40 in total

1.  Tlx3 and Runx1 act in combination to coordinate the development of a cohort of nociceptors, thermoceptors, and pruriceptors.

Authors:  Claudia Lopes; Zijing Liu; Yi Xu; Qiufu Ma
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

Review 2.  Transcriptional regulation of neuronal phenotype in mammals.

Authors:  Qiufu Ma
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

3.  Brn3a and Islet1 act epistatically to regulate the gene expression program of sensory differentiation.

Authors:  Iain M Dykes; Lynne Tempest; Su-In Lee; Eric E Turner
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

4.  Role of the dorsal medial habenula in the regulation of voluntary activity, motor function, hedonic state, and primary reinforcement.

Authors:  Yun-Wei A Hsu; Si D Wang; Shirong Wang; Glenn Morton; Hatim A Zariwala; Horacio O de la Iglesia; Eric E Turner
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

5.  Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development.

Authors:  Lely A Quina; Shirong Wang; Lydia Ng; Eric E Turner
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

6.  Regulation of the development of tectal neurons and their projections by transcription factors Brn3a and Pax7.

Authors:  Natalia Fedtsova; Lely A Quina; Shirong Wang; Eric E Turner
Journal:  Dev Biol       Date:  2008-01-05       Impact factor: 3.582

7.  Brn-3a deficiency transiently increases expression of calbindin D-28 k and calretinin in the trigeminal ganglion during embryonic development.

Authors:  Hiroyuki Ichikawa; Ruji Terayama; Tomoichiro Yamaai; David M Jacobowitz; Feng Qiu; Mengging Xiang; Tomosada Sugimoto
Journal:  Cell Mol Neurobiol       Date:  2009-03-14       Impact factor: 5.046

8.  Neuropilin 1 and 2 control cranial gangliogenesis and axon guidance through neural crest cells.

Authors:  Quenten Schwarz; Joaquim M Vieira; Beatrice Howard; Britta J Eickholt; Christiana Ruhrberg
Journal:  Development       Date:  2008-03-20       Impact factor: 6.868

9.  Neuropilin-mediated neural crest cell guidance is essential to organise sensory neurons into segmented dorsal root ganglia.

Authors:  Quenten Schwarz; Charlotte H Maden; Kathryn Davidson; Christiana Ruhrberg
Journal:  Development       Date:  2009-04-22       Impact factor: 6.868

10.  Brn3a regulates neuronal subtype specification in the trigeminal ganglion by promoting Runx expression during sensory differentiation.

Authors:  Iain M Dykes; Jason Lanier; S Raisa Eng; Eric E Turner
Journal:  Neural Dev       Date:  2010-01-22       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.